Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Accelerating the Commercialization of Biosimilar Medicines in India
Sartorius Stedim Biotech
A SMART Platform for Scalable Biotherapeutic Development: cDNA to 200L Single-Use Stirred-Tank Bioreactor
Process Analytical Technology For Upstream Bioprocessing
Erica Fratz-Berilla and Cyrus Agarabi, FDA CDER
Continuous Bioprocessing: PAT Strategies in Support of Process Monitoring and Control to Enable Rapid Product Release
By: Jeffrey Doyle, Manager, PAT Projects in the Process Analytical Sciences Group
Paul Jeffers, Manager, PAT Projects in Process Analytical Sciences Group, Global Technology Services
Seamus O’Neill, Analytical Chemist
Pfizer
Headline News
FDA expands CAMZYOS approval to paediatric patients with obstructive hypertrophic cardiomyopathy
ICOTYDE maintains skin clearance through two years in difficult to treat plaque psoriasis
AstraZeneca, Daiichi Sankyo and Summit to study Datroway plus ivonescimab across multiple cancers
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Validation Of Endotoxin Testing For CAR T-cell Manufacturing Quality Control & Benefits of Cartridge Technology
Presented by Dr. Zlatibor Velickovic PhD Production Manager | Department of Cell & Molecular Therapies, Royal Prince Alfred Hospital Sydney, Australia, ISCT Regional Vice-President Elect, Australia & New Zealand and Alan Hoffmeister Senior Global Technology & Market Development Manager, Charles River Laboratories
28th October 2021
Accelerating the development of regenerative therapies: Large scale expansion of human mesenchymal stem cells
Presented by Jon Rowley, Ph.D. & Mark Szczypka, Ph.D.
28th March 2017
Annex 1 and Environmental Monitoring Program – Implementation And Justification of The Best Practices In Routine
Presented by Presented by Benoit Ramond, Head of Microbiology & Sterile Technology at Sanofi and Laurent Leblanc, 3P Ecosytem R&D Manager at bioMérieux
19th October 2022
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Strategy Emerging Markets for Risk Mitigation
Push-Button Simplicity: Automatic Fermentation with the BioFlo® 120 Auto Culture Mode
From Compliance to Circularity: Three Ways Pharma Manufacturers Can Rethink Resource Management
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
